Cargando…
Light therapy for multiple sclerosis-associated fatigue: Study protocol for a randomized controlled trial
BACKGROUND: Fatigue is the most commonly reported symptom among multiple sclerosis (MS) patients, more than a quarter of whom consider fatigue to be their most disabling symptom. However, there are few effective treatment options for fatigue. We aim to investigate whether supplemental exposure to br...
Autores principales: | Mateen, Farrah J., Manalo, Natalie C., Grundy, Sara J., Houghton, Melissa A., Hotan, Gladia C., Erickson, Hans, Videnovic, Aleksandar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392596/ https://www.ncbi.nlm.nih.gov/pubmed/28885372 http://dx.doi.org/10.1097/MD.0000000000008037 |
Ejemplares similares
-
Progressive multifocal leukoencephalopathy: A 25-year retrospective cohort study
por: Anand, Pria, et al.
Publicado: (2019) -
Is It Time for Quotas to Achieve Racial and Ethnic Representation in Multiple Sclerosis Trials?
por: Mateen, Farrah J.
Publicado: (2021) -
Switching state-space modeling of neural signal dynamics
por: He, Mingjian, et al.
Publicado: (2023) -
Risk factors for COVID-19 infection in patients with multiple sclerosis: a nested case–control study
por: Uhr, Lauren, et al.
Publicado: (2021) -
Impact of the COVID-19 pandemic on the health care of >1,000 People living with multiple sclerosis: A cross-sectional study
por: Vogel, Andre C., et al.
Publicado: (2020)